Position in OGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$266,697
+$174,090 QoQ
Shares Held
19,697
+52.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#218
of 626 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $404,940,719 across 16 Drug Manufacturers - General names. OGN ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
154,543 | $185,363,525 | |
| 2 | AMGN |
Amgen Inc
|
173,024 | $62,655,450 | |
| 3 | JNJ |
Johnson & Johnson
|
203,267 | $51,623,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
292,117 | $37,537,034 | |
| 5 | ABBV |
AbbVie Inc.
|
94,884 | $23,876,609 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
179,874 | $10,364,339 | |
| 7 | PFE |
Pfizer Inc
|
332,178 | $7,998,846 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
58,662 | $7,411,357 |
All Filings in OGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,697 | 19,697 | Shares | Sole | 2026-07-17 | |
| 2025-12-31 | $92,607 | 12,916 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $124,742 | 11,680 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $110,226 | 11,387 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $288,746 | 19,392 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $203,419 | 13,634 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $550,484 | 28,776 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $250,863 | 12,119 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $230,638 | 12,268 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||